Works matching IS 09650407 AND DT 2023 AND VI 31 AND IP 3

Results: 14

Transcriptome analysis reveals tumor antigen and immune subtypes of melanoma.

Published in:

Oncology Research, 2023, v. 31, n. 3, p. 389, doi. 10.32604/or.2023.029274

By:

JIAHENG XIE;
MENGMENG OU;
PAN YU;
DAN WU;
QIKAI TANG;
YUAN CAO;
JING HANG;
LU YIN;
TINGHONG XIANG;
MING WANG;
JINGPING SHI

Publication type:

Article

The role of AFAP1-AS1 in mitotic catastrophe and metastasis of triple-negative breast cancer cells by activating the PLK1 signaling pathway.

Published in:

Oncology Research, 2023, v. 31, n. 3, p. 375, doi. 10.32604/or.2023.028256

By:

SHUIZHONG CEN;
XIAOJIE PENG;
JIANWEN DENG;
HAIYUN JIN;
ZHINAN DENG;
XIAOHUA LIN;
DI ZHU;
MING JIN;
YANWEN ZHU;
PUSHENG ZHANG;
YUNFENG LUO;
HONGYAN HUANG

Publication type:

Article

Senescent mesenchymal stem/stromal cells in pre-metastatic bone marrow of untreated advanced breast cancer patients.

Published in:

Oncology Research, 2023, v. 31, n. 3, p. 361, doi. 10.32604/or.2023.028104

By:

BORZONE, FRANCISCO RAÚL;
GIORELLO, MARÍA BELÉN;
MARTINEZ, LEANDRO MARCELO;
SANMARTIN, MARÍA CECILIA;
FELDMAN, LEONARDO;
DIMASE, FEDERICO;
BATAGELJ, EMILIO;
YANNARELLI, GUSTAVO;
CHASSEING, NORMA ALEJANDRA

Publication type:

Article

Mechanism of NURP1 in temozolomide resistance in hypoxia-treated glioma cells via the KDM3A/TFEB axis.

Published in:

Oncology Research, 2023, v. 31, n. 3, p. 345, doi. 10.32604/or.2023.028724

By:

TAO LI;
XIN FU;
JIE WANG;
WEI SHANG;
XIAOTONG WANG;
LINYUN ZHANG;
JUN LI

Publication type:

Article

Drug repositioning of disulfiram induces endometrioid epithelial ovarian cancer cell death via the both apoptosis and cuproptosis pathways.

Published in:

Oncology Research, 2023, v. 31, n. 3, p. 333, doi. 10.32604/or.2023.028694

By:

YAPING GAN;
TING LIU;
WEIFENG FENG;
LIANG WANG;
LI LI;
YINGXIA NING

Publication type:

Article

Calcyclin-binding protein contributes to cholangiocarcinoma progression by inhibiting ubiquitination of MCM2.

Published in:

Oncology Research, 2023, v. 31, n. 3, p. 317, doi. 10.32604/or.2023.028418

By:

YUSEN ZHANG;
LIPING LIU;
BIWEI LUO;
HONGGUI TANG;
XIAOFANG YU;
SHIYUN BAO

Publication type:

Article

The zinc figure protein ZNF575 impairs colorectal cancer growth via promoting p53 transcription.

Published in:

Oncology Research, 2023, v. 31, n. 3, p. 307, doi. 10.32604/or.2023.028564

By:

NING AN;
HEQING PENG;
MIN HOU;
DUOFENG SU;
LIU WANG;
XIAOGANG SHEN;
MING ZHANG

Publication type:

Article

Multi-institutional analysis of cervical esophageal carcinoma patients treated with definitive chemoradiotherapy: TROD 01-005 study.

Published in:

Oncology Research, 2023, v. 31, n. 3, p. 299, doi. 10.32604/or.2023.028840

By:

GULER, OZAN CEM;
OYMAK, EZGI;
YAZICI, GOZDE;
AKAGUNDUZ, OZLEM OZKAYA;
CETINAYAK, OGUZ;
ERPOLAT, PETEK;
AKSOY, ATIL;
DUZOVA, MURSEL;
YILDIRIM, BERNA AKKUS;
KURT, MERAL;
CANYILMAZ, EMINE;
YAVAS, GULER;
AKYUREK, SERAP;
OKSUZ, DIDEM COLPAN;
SAGLAM, ESRA KAYTAN;
CELIK, OMUR KARAKOYUN;
OZYAR, ENIS;
CENGIZ, MUSTAFA;
ONAL, CEM

Publication type:

Article

Apolipoprotein C1 promotes tumor progression in gastric cancer.

Published in:

Oncology Research, 2023, v. 31, n. 3, p. 287, doi. 10.32604/or.2023.028124

By:

QIOU GU;
TIAN ZHAN;
XIAO GUAN;
CHUILIN LAI;
NA LU;
GUOGUANG WANG;
LEI XU;
XIANG GAO;
JIANPING ZHANG

Publication type:

Article

High expression of PD-L1 mainly occurs in non-small cell lung cancer patients with squamous cell carcinoma or poor differentiation.

Published in:

Oncology Research, 2023, v. 31, n. 3, p. 275, doi. 10.32604/or.2023.028227

By:

LU LIU;
BIN XIE;
WEI ZHU;
QIUYAN HE;
JIANHUA ZHOU;
SHUANG LIU;
YONGGUANG TAO;
DESHENG XIAO

Publication type:

Article

Liquid biopsy and blood-based minimal residual disease evaluation in multiple myeloma.

Published in:

Oncology Research, 2023, v. 31, n. 3, p. 271, doi. 10.32604/or.2023.028668

By:

GOZZETTI, ALESSANDRO;
BOCCHIA, MONICA

Publication type:

Article

Review and prospect of immune checkpoint blockade therapy represented by PD-1/PD-L1 in the treatment of clear cell renal cell carcinoma.

Published in:

Oncology Research, 2023, v. 31, n. 3, p. 255, doi. 10.32604/or.2023.027942

By:

WENFEI GE;
SHIYAN SONG;
XIAOCHEN QI;
FENG CHEN;
XIANGYU CHE;
YONGHAO SUN;
JIN WANG;
XIAOWEI LI;
NANA LIU;
QIFEI WANG;
GUANGZHEN WU

Publication type:

Article

PPARα activator irbesartan suppresses the proliferation of endometrial carcinoma cells via SREBP1 and ARID1A.

Published in:

Oncology Research, 2023, v. 31, n. 3, p. 239, doi. 10.32604/or.2023.026067

By:

YU LU;
TSUTOMU MIYAMOTO;
HODAKA TAKEUCHI;
FUMI TSUNODA;
NAOKI TANAKA;
TANRI SHIOZAWA

Publication type:

Article

Targeting triple-negative breast cancer: A clinical perspective.

Published in:

Oncology Research, 2023, v. 31, n. 3, p. 221, doi. 10.32604/or.2023.028525

By:

POPOVIC, LAZAR S.;
MATOVINA-BRKO, GORANA;
POPOVIC, MAJA;
PUNIE, KEVIN;
CVETANOVIC, ANA;
LAMBERTINI, MATTEO

Publication type:

Article